Company
Our Story & Team
Who We Are
Leadership
Board of Directors
Scientific Advisory Boards
More Information
Corporate Contact
Partners & Collaborators
Press Releases
Science
Get Started
Platforms
Pipeline
Publications
Explore
piggyBac
®
Cas-CLOVER
™
Gene Delivery
CAR-T Tools
CAR-T Therapies
Gene Therapies
Patients
For Patients
Our Approach
Expanded Access
Explore
Our CAR-T Therapies
Our Gene Therapies
Clinical Trials
Investors and Media
Overview
Corporate Profile
Press Releases
Poseida News Center
Events & Presentations
Publications
Financials & Filings
SEC Filings
Quarterly Results
Stock Information
Stock Quote & Chart
Email Alerts
Covering Analysts
Corporate Governance
Documents & Charters
Board of Directors
Committee Composition
IR Contact
Careers
Life at Poseida
Join Our Team
Our Culture
Benefits
Explore
Jobs
Press Releases
Developing Nonviral Gene Therapy for Hemophilia A
« back
CGTLive
| January 9, 2023
MENU
Company
Our Story & Team
Who We Are
Leadership
Board of Directors
Scientific Advisory Boards
More Information
Corporate Contact
Partners & Collaborators
Press Releases
Science
Get Started
Platforms
Pipeline
Publications
Explore
piggyBac
®
Cas-CLOVER
™
Gene Delivery
CAR-T Tools
CAR-T Therapies
Gene Therapies
Patients
For Patients
Our Approach
Expanded Access
Explore
Our CAR-T Therapies
Our Gene Therapies
Clinical Trials
Investors and Media
Overview
Corporate Profile
Press Releases
Poseida News Center
Events & Presentations
Publications
Financials & Filings
SEC Filings
Quarterly Results
Stock Information
Stock Quote & Chart
Email Alerts
Covering Analysts
Corporate Governance
Documents & Charters
Board of Directors
Committee Composition
IR Contact
Careers
Life at Poseida
Join Our Team
Our Culture
Benefits
Explore
Jobs